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Abstract 
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative tauopathy found in individuals with 
a history of repetitive head impacts (RHI). Previous work has demonstrated that neuroinflammation is involved 
in CTE pathogenesis, however, the specific inflammatory mechanisms are still unclear. Here, using RNA-sequenc-
ing and gene set enrichment analysis (GSEA), we investigated the genetic changes found in tissue taken from the 
region CTE pathology is first found, the cortical sulcus, and compared it to neighboring gryal crest tissue to iden-
tify what pathways were directly related to initial hyperphosphorylated tau (p-tau) deposition. 21 cases were 
chosen for analysis: 6 cases had no exposure to RHI or presence of neurodegenerative disease (Control), 5 cases 
had exposure to RHI but no presence of neurodegenerative disease (RHI), and 10 cases had exposure to RHI and 
low stage CTE (CTE). Two sets of genes were identified: genes that changed in both the sulcus and crest and 
genes that changed specifically in the sulcus relative to the crest. When examining genes that changed in both 
the sulcus and crest, GSEA demonstrated an increase in immune related processes and a decrease in neuronal 
processes in RHI and CTE groups. Sulcal specific alterations were observed to be driven by three mechanisms: 
anatomy, RHI, or p-tau. First, we observed consistent sulcal specific alterations in immune, extracellular matrix, 
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vascular, neuronal, and endocytosis/exocytosis categories across all groups, suggesting the sulcus has a unique 
molecular signature compared to the neighboring crest independent of pathology. Second, individuals with a 
history of RHI demonstrated impairment in metabolic and mitochondrial related processes. Finally, in individuals 
with CTE, we observed impairment of immune and phagocytic related processes. Overall, this work provides the 
first observation of biological processes specifically altered in the sulcus that could be directly implicated in CTE 
pathogenesis and provide novel targets for biomarkers and therapies. 
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Introduction 
Chronic traumatic encephalopathy (CTE) is a 
progressive neurodegenerative disease found in in-
dividuals with a history of exposure to repetitive 
head impacts (RHI) typically received through play-
ing contact sports such as American football, 
hockey, soccer, boxing, or rugby, or through military 
service-related injuries like blasts [3, 23, 24]. Cur-
rently, CTE can only be definitively diagnosed after 
death through neuropathologic autopsy. The path-
ognomonic lesion that defines the disease consists 
of perivascular hyperphosphorylated tau (p-tau) 
found in neurons and sometimes astrocytes, initially 
at the depths of the cortical sulcus in the frontal cor-
tex [3]. Through computational modeling and hel-
met sensor data, it was observed that the sulcus and 
blood vessels receive the greatest amount of dam-
age after head trauma, directly linking RHI induced 
trauma to CTE pathogenesis [11]. However, the spe-
cific biological response after trauma that drives CTE 
pathology is still unclear. 
Under normal circumstances, inflammation is a 
necessary part of the injury cascade. In the brain, 
neuroinflammation has been observed to be neces-
sary for wound healing responses after damage, trig-
gering an innate and adaptive immune response to 
fight infectious agents, and recruit beneficial im-
mune cells to areas of need [6]. However, prolonged 
or chronic inflammation can be harmful and can re-
sult in tissue damage and long-term pathology. RHI 
has been shown to induce a chronic neuroinflamma-
tory environment in both mouse and human studies 
[9, 10, 32]. Additionally, previous work from our la-
boratory has demonstrated that elevated microglial 
recruitment via the chemokine CCL2, and glial acti-
vation was related to greater years playing contact 
sports and is a prominent feature in CTE [4, 7]. We 
observed that microglia-mediated neuroinflamma-
tion may exist in a feedback loop with p-tau pathol-
ogy. Neuroinflammation induces p-tau deposition, 
which in turn induces more neuroinflammation 
leading to a vicious cycle, similar to the inflamma-
tory cascade hypothesis in Alzheimer’s disease (AD) 
[12, 16]. However, the concept of neuroinflamma-
tion is broad, encompassing inflammatory, anti-in-
flammatory, senescent, and immunoregulatory fea-
tures that previous histology-based studies were un-
able to easily segregate [6]. Therefore, there is a crit-
ical need to understand the individual inflammatory 
phenotypes that emerge during RHI to have more 
complete insight into the various mechanisms which 
may directly result in CTE pathogenesis. To help fill 
in knowledge gaps, high level bioinformatic analyses 
are needed. Previous studies have demonstrated 
that high throughput genomic techniques and bioin-
formatic pipelines are an optimal method to investi-
gate large scale changes in the brain and determine 
specific pathways and effects in a more efficient 
manner [1, 17]. 
Herein, we utilized bulk tissue RNA-sequencing 
targeted to cortical anatomy, in order to investigate 
the spectrum of inflammatory and neurodegenera-
tive phenotypes that occur as a result of RHI and 
during early stage CTE. As the earliest neuropatho-
logic feature of CTE is p-tau pathology found at the 
depth of the cortical sulcus, we chose to examine 
what genetic changes occur specifically in the sulcus 
compared to the neighboring gyral crest. By directly 
comparing between the sulcus and crest within each 
case, we will have unique insights into which genes 
or biological processes are specifically altered in the 
sulcus as opposed to genes that are part of a more 
tissue wide response. We will utilize three separate 









ferent  stages  of  disease.  Furthermore,  the  results 
will  provide  new  understandings  and  insight  into 
what  genes  and  biological  processes  might  be  di‐
rectly related to  initial CTE p‐tau deposition as op‐
posed to a general CNS response to trauma. Finally, 







selected  from  the  Understanding  Neurological  In‐










tional  Post‐Traumatic  Stress  Disorder  (PTSD)  brain 
bank  (National  Center  for  PTSD,  VA  Boston 
Healthcare  System,  Boston  MA).  These  6  donors 
were selected from a group that lacked a history of 
RHI, did not have evidence of a neurodegenerative 
disease  at  autopsy,  and  were  not  diagnosed  with 
PTSD in life. Samples were grouped into three cate‐
gories:  6  cases  with  no  history  of  repetitive  head 









statistics  for  the  age  at  death,  years  of  exposure, 
sport played,  and RNA  integrity number  (RIN),  are 
provided in Table 1. 





of  the  Boston  University  School  of  Medicine,  and 










Post‐mortem  fresh  frozen  tissue  from  the 
dorsolateral frontal cortex was obtained using pre‐
viously  described  procedures  [4].  Neuropathologic 
diagnosis was obtained from formalin fixed paraffin 
embedded  tissue  as  previously  described  [21,  24]. 
Briefly,  22  sections  of  paraffin  embedded  tissue 
were  stained  for hyperphosphorylated  tau  (p‐tau), 
alpha‐synuclein,  amyloid  beta,  TDP‐43,  luxol  fast 
blue,  and  hematoxylin  and  eosin  using  previously 
described methods [22]. A neuropathologic diagno‐
sis of CTE was made using National Institute of Neu‐






The  low  stage  CTE  designation  encompasses  CTE 
stage I&II [2, 21] and shows strong agreement with 
the  recent NINDS  consensus  staging  for  low  stage 
CTE  [3].  Neuropathologic  examination  occurred 
blinded  to  clinical  results.  All  evaluations were  re‐
viewed by four neuropathologists (VA, BH, TS, AM); 
discrepancies in the diagnosis were resolved by con‐












cortical  sulcus  (defined as  the bottom  third of  the 
sulcus) and the associated neighboring gryal crest at 
the level of the anterior caudate nucleus. Frozen tis‐
sue  was  process  using  a  mortar  and  pestle,  and 
mRNA was extracted and  isolated using a Maxwell 
RNA extraction kit  (Promega) as per manufactures 
instruction.  An  Ion  Apliseq  Transcriptome  Human 





generation  sequencer  (ThermoFisher  Scientific). 
Samples  were  processed  and  run  across  two 
batches. Batch one  contained 6  control  and 6 CTE 
cases,  and  batch  two  contained  5  RHI  and  4  CTE 
cases and were compared separately to avoid batch 
effects. Normalized counts for each sample were de‐
termined using  the  Ion Torrent  Suit  Software 5.10 
and  concatenated  together  into  genes  by  sample 
count  matrix.  The  normalized  counts  were  then 









lyze  changes  between  the  sulcus  and  crest within 
each  group,  a  ratio  between  the  sulcus  and  crest 
genes were calculated using the concatenated nor‐
malized counts matrix. Genes that could not be de‐




log  2  of  sulcus  counts  divided  by  crest  counts  for 




using  the  NumPy  python  package.  This  procedure 
results  in  a  log2  fold  change of  sulcus  vs  crest  for 
each gene in each sample. To identify genes that ex‐
hibited  significantly  different  expression  between 
tissues  within  each  case  status,  one‐sample,  two‐
tailed t‐tests comparing with an expected mean log2 
fold  change  of  zero  were  performed  for  the  fold 














tations  from  GOAtools  python  package  [14,  29]. 
GSEA statistics were calculated using gene list sorted 
by descending  log2 fold change (from DE) or  log 2 
ratio  t‐statistics,  and  significance was  assessed  for 
gene sets at FDR < 0.1. The resulting normalized en‐
richment  scores  (NES)  were  then  used  to  create 
heatmaps.  GSEA  biological  process  were  grouped 
into 1 out of 11 biological categories by hand, based 
on  expert  opinion.  Categories were  discussed  and 
confirmed among 3 authors (JC, AL, TS). Any differ‐
ences were resolved through consensus conference. 
The  biological  categories  were:  immune,  vascular, 




ous  10  category  was  assigned  to  “other”.  Finally, 
gene  ontology  analysis  from  common  or  unique 
genes groups was carried out using Metascape [33]. 
All code and supplementary information needed to 





lined  in  Figure  1.  The  first  analysis was  to  directly 















were  significantly  altered  (nominal  p  <  0.05)  in  at 
least one region were plotted against each other to 
examine if there were similar direction changes oc‐










Comparison  3  uses  the  ratio  created  from  comparison  2  and 
compares that sulcus vs crest ratio from RHI and CTE groups to 
the  control  group  to determine how  the  sulcal  specific  genes 
changes over the course of disease. 
 


























logical processes  that are altered  in CTE  (Table 3). 















riched  neuronal  processes  (4.9%).  Most  signaling 
processes  were  negatively  enriched  (20.6%)  com‐
pared  to  positively  enriched  (4.9%).  Mitochondria 


























category  with  30.6%  of  processes.  No  ECM  pro‐
cesses  were  negatively  enriched.  Neuronal  pro‐
cesses were the majority of negatively enriched pro‐
cesses (85.7%) and were higher than positively en‐
riched  neuronal  processes.  The  only  other  nega‐
tively  enriched  process  was  transcription/transla‐





















579 were  increased  in  the  sulcus and 92 were de‐
creased in the sulcus compared to the crest (Figure 
4A).  For  cases  in  the  RHI  group,  1926  genes were 
found to have a nominal p < 0.05. However, only 1 
gene, MANEA,  reached FDR corrected significance. 










GSEA  analysis  clarifies  biological  response  pro‐
cesses that are occurring in the sulcus in each con‐
dition 
To  further  explore how  the  sulcal  specific  re‐














































compare  enrichment  of  each  biological  process 
across groups and determine if there were similar or 
different directions of effect (Figure 5). For added 
Immune Vascular Neuronal ECM Mitochondria
olfactory receptor activity






cellular response to fibroblast growth factor stimulus




cellular response to interferon-gamma
cytokine activity
response to glucocorticoid
positive regulation of ERK1 and ERK2 cascade




transmembrane signaling receptor activity
perikaryon
voltage-gated potassium channel complex
G protein-coupled receptor activity
mitochondrial inner membrane
cochlea development
potassium ion transmembrane transport
voltage-gated potassium channel activity
mitochondrial large ribosomal subunit
axon terminus
mitochondrial electron transport, NADH to ubiquinone
mitochondrial respiratory chain complex I assembly
synaptic vesicle membrane
regulation of sodium ion transmembrane transporter activity
type I interferon signaling pathway
extracellular matrix structural constituent
extracellular matrix
external side of plasma membrane
regulation of immune response
extracellular matrix organization
defense response to Gram-negative bacterium
defense response to bacterium






nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
cellular response to cadmium ion
iron ion homeostasis
positive regulation of tumor necrosis factor production
toll-like receptor signaling pathway
phagocytosis
anchored component of membrane












regulation of cytoskeleton organization
cellular oxidant detoxification
inflammatory response
cellular response to lipopolysaccharide
heme binding
secretory granule lumen




positive regulation of NF-kappaB transcription factor activity
immune response
leukocyte migration
non-membrane spanning protein tyrosine kinase activity
Crest Sulcus
CTE vs Control
NES Compared to Control
synaptic vesicle membrane
integral component of postsynaptic density membrane
terminal bouton
axon initial segment






regulation of cell shape
membrane raft
focal adhesion
cell surface receptor signaling pathway
collagen-containing extracellular matrix
cell migration




negative regulation of TGFb receptor signaling pathway
regulation of immune response
platelet degranulation
cellular response to mechanical stimulus
phagocytic vesicle membrane
Z disc
extracellular matrix structural constituent






cellular response to interferon-gamma
complement activation
complement activation, classical pathway
adaptive immune response
extracellular matrix organization
positive regulation of cytosolic calcium ion concentration
immune response
inflammatory response
positive regulation of PI3K signaling



























51  (13.7%)  processes.  The  majority  of  processes 







riched  in  the  sulcus  compared  to  the  crest  (Figure 
5B). The category with the most assigned processes 






toskeletal  processes.  The  ECM  category  had  34 
(6.4%) processes. All  the processes were positively 
enriched in control cases. However, there was a pos‐
sible  progressive  increase  in  negatively  enriched 
processes  through  RHI  and  CTE  (Figure  5E). Mito‐
chondria  had  24  (6.4%)  associated  processes.  The 
RHI group only had 1 negatively enriched pathway 
while control and CTE had a mixed split of positive 
and  negative  processes  (Figure  5F).  The  signaling 
category had 56 (15.0%) processes and was evenly 
split between positive and negative enrichment (Fig‐




ure  5H).  The  endocytosis/exocytosis  category  had 
13 (3.5%) processes and was primarily negatively en‐
riched  in  the  sulcus  (Figure  5I).  The  protein  pro‐
cessing category had 16 (4.3%) processes and was a 

















ficantly  altered  in  the  sulcus 
compared to the crest, we used 
GSEA  to  identify  biological  pro‐
cesses.  Each  process  was  then 
assigned to a greater overall bio‐
logical  category:  A)  Immune,  B) 
Transcriptional/translational,  C) 
Neuronal,  D)  Cytoskeletal,  E) 










antigen processing and presentation of exogenous peptide antigen via MHC class II
macroautophagy
cellular response to organic substance
Fc-gamma receptor signaling pathway involved in phagocytosis
cell migration
positive regulation of chemokine production
acute-phase response
amyloid-beta binding
negative regulation of cell population proliferation
platelet degranulation
negative regulation of apoptotic process




negative regulation of signaling receptor activity
transforming growth factor beta binding
antigen processing and presentation of peptide antigen via MHC class I
positive regulation of I-kappaB kinase/NF-kappaB signaling
regulation of immune response
positive regulation of cell population proliferation
cell differentiation





cellular response to mechanical stimulus
scavenger receptor activity
astrocyte activation
negative regulation of osteoblast differentiation
wound healing
transforming growth factor beta receptor signaling pathway
negative regulation of G1/S transition of mitotic cell cycle
DNA damage response, signal transduction by p53 class mediator
activation of cysteine-type endopeptidase activity involved in apoptotic process
type I interferon signaling pathway
tissue regeneration
negative regulation of growth
negative regulation of chondrocyte differentiation
apoptotic cell clearance




defense response to virus
astrocyte development
negative regulation of viral entry into host cell
protein targeting to peroxisome
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
G protein-coupled serotonin receptor signaling pathway
response to amphetamine
calcium-dependent phospholipid binding
ubiquitin conjugating enzyme activity
Arp2/3 complex-mediated actin nucleation
G protein-coupled serotonin receptor activity
cell junction
ephrin receptor signaling pathway
MAP kinase kinase activity
regulation of insulin secretion






Rab protein signal transduction
phospholipase activity
NAD+ kinase activity







cellular response to BMP stimulus
serine-type endopeptidase inhibitor activity




Rho protein signal transduction
response to progesterone
negative regulation of canonical Wnt signaling pathway
cellular response to platelet-derived growth factor stimulus
positive regulation of cholesterol efflux
mitogen-activated protein kinase binding
regulation of Notch signaling pathway
hippo signaling





cellular response to epidermal growth factor stimulus
positive regulation of phosphatidylinositol 3-kinase signaling
small GTPase binding




ATPase-coupled transmembrane transporter activity
negative regulation of protein kinase B signaling
platelet-derived growth factor receptor signaling pathway
regulation of DNA-binding transcription factor activity
protein ubiquitination
positive regulation of telomere capping
positive regulation of telomerase RNA localization to Cajal body





structural constituent of ribosome
translational initiation
polysomal ribosome
cytosolic small ribosomal subunit
cytosolic large ribosomal subunit




regulation of transcription, DNA-templated
protein ADP-ribosylase activity
chromatin
RNA polymerase II transcription factor binding
RNA polymerase II cis-regulatory region sequence-specific DNA binding
positive regulation of gene expression
histone deacetylase binding
DNA-binding transcription repressor activity, RNA polymerase II-specific
chromatin binding
transcription regulatory region sequence-specific DNA binding
DNA-binding transcription activator activity, RNA polymerase II-specific
negative regulation of gene expression
intracellular protein transport






negative regulation of phosphoprotein phosphatase activity
NADH dehydrogenase (ubiquinone) activity
carboxypeptidase activity
SRP-dependent cotranslational protein targeting to membrane
ubiquitin protein ligase binding
positive regulation of tyrosine phosphorylation of STAT protein
protein processing
endoplasmic reticulum lumen













positive regulation of receptor-mediated endocytosis

























flavin adenine dinucleotide binding
animal organ regeneration
myosin V binding












regulation of postsynaptic membrane potential
positive regulation of dendritic spine morphogenesis





regulation of dopamine secretion
voltage-gated potassium channel complex
synaptic transmission, glutamatergic
Schaffer collateral - CA1 synapse
regulation of synaptic plasticity
neurotransmitter receptor activity
terminal bouton
positive regulation of excitatory postsynaptic potential
AMPA glutamate receptor complex
integral component of presynaptic membrane
voltage-gated calcium channel complex
regulation of calcium ion-dependent exocytosis
integral component of postsynaptic membrane
long-term memory




positive regulation of calcium ion-dependent exocytosis
presynaptic active zone
glutamate secretion
regulation of synaptic vesicle exocytosis
potassium ion transmembrane transport









sensory perception of pain
perikaryon
neuronal cell body




extracellular ligand-gated ion channel activity
nervous system process
calmodulin-dependent protein kinase activity
long-term synaptic potentiation
dendrite membrane
regulation of NMDA receptor activity
axonogenesis




positive regulation of dendrite extension
stabilization of membrane potential






regulation of membrane potential
nervous system development
regulation of ion transmembrane transport
presynapse
transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential
calcium channel regulator activity
ion transport
axon extension






integral component of postsynaptic density membrane
glutamatergic synapse







negative regulation of neuron apoptotic process
iron ion homeostasis
detection of chemical stimulus involved in sensory perception of bitter taste
somatic stem cell population maintenance
negative regulation of neurogenesis
negative regulation of neuron differentiation
myelination
oligodendrocyte development








substrate adhesion-dependent cell spreading
basement membrane
positive regulation of epithelial cell migration
basolateral plasma membrane
cell adhesion
extracellular matrix structural constituent
collagen binding
cell-matrix adhesion
bicellular tight junction assembly
bone remodeling
ruffle membrane









establishment or maintenance of epithelial cell apical/basal polarity
external side of plasma membrane





positive regulation of epithelial to mesenchymal transition
apical part of cell
ECM
mitochondrial respiratory chain complex I assembly





mitochondrial calcium ion transmembrane transport
mitochondrial electron transport, NADH to ubiquinone
mitochondrial respiratory chain complex I
regulation of cellular amino acid metabolic process
protein import into mitochondrial matrix




linoleic acid metabolic process
fatty acid beta-oxidation
lipid transport








outflow tract septum morphogenesis
outflow tract morphogenesis
regulation of blood pressure
blood vessel development
negative regulation of blood vessel endothelial cell migration
positive regulation of blood vessel endothelial cell migration
sprouting angiogenesis
vasculogenesis
positive regulation of angiogenesis
regulation of angiogenesis
negative regulation of angiogenesis
blood microparticle






































that  were  found  to  be  specifi‐
cally  altered  in  the  sulcus were 
compared  to  the  control.  Each 
process was again assigned to a 
greater  overall  biological  cate‐
gory: A) Immune, B) Transcripti‐
onal/translational,  C)  Neuronal, 





negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
response to lipopolysaccharide
type I interferon signaling pathway
phagocytosis
MyD88-dependent toll-like receptor signaling pathway
toll-like receptor signaling pathway
positive regulation of tumor necrosis factor production
positive regulation of interleukin-8 production
positive regulation of phagocytosis
positive regulation of NIK/NF-kappaB signaling
positive regulation of I-kappaB kinase/NF-kappaB signaling
cytokine-mediated signaling pathway
inammatory response
positive regulation of cell population proliferation
negative regulation of cell population proliferation
interferon-gamma-mediated signaling pathway
negative regulation of extrinsic apoptotic signaling pathway
response to cytokine
necroptotic process
positive regulation of interleukin-6 production
negative regulation of B cell proliferation
leukocyte migration
transforming growth factor beta receptor signaling pathway
astrocyte activation
transforming growth factor beta binding




cellular response to mechanical stimulus
cell migration
positive regulation of cell migration
cell dierentiation
negative regulation of G0 to G1 transition
negative regulation of apoptotic process
apoptotic process
regulation of defense response to virus by virus
positive regulation of viral transcription
immunological synapse
T cell receptor signaling pathway
tumor necrosis factor-mediated signaling pathway





negative regulation of G2/M transition of mitotic cell cycle
interleukin-1-mediated signaling pathway
antigen processing and presentation of exogenous peptide antigen via MHC class II
NIK/NF-kappaB signaling
proteasome accessory complex




positive regulation of cell migration involved in sprouting angiogenesis
sprouting angiogenesis
positive regulation of blood vessel endothelial cell migration
erythrocyte development
branching involved in blood vessel morphogenesis









regulation of hematopoietic stem cell dierentiation
ion channel activity
positive regulation of neural precursor cell proliferation
outflow tract morphogenesis
neuronal stem cell population maintenance
iron ion homeostasis

























regulation of dopamine secretion
fibronectin binding
epithelial to mesenchymal transition
integrin-mediated signaling pathway
regulation of bone mineralization
filopodium membrane
integrin binding
extracellular matrix structural constituent conferring tensile strength
cell-cell adhesion
cell-matrix adhesion






extracellular matrix structural constituent
lamellipodium






positive regulation of cell-substrate adhesion
cell-substrate adhesion
glycogen metabolic process
cellular protein metabolic process
long-chain fatty-acyl-CoA biosynthetic process
cholesterol transport




mitochondrial calcium ion transmembrane transport
mitochondrial ribosome
mitochondrial large ribosomal subunit
regulation of cellular amino acid metabolic process
mitochondrial electron transport, NADH to ubiquinone
mitochondrial respiratory chain complex I
mitochondrial respiratory chain complex I assembly
mitochondrial electron transport, cytochrome c to oxygen
protein import into mitochondrial matrix




positive regulation of transcription of Notch receptor target
Notch signaling pathway




MAP kinase kinase kinase activity
negative regulation of ERK1 and ERK2 cascade
cellular response to platelet-derived growth factor stimulus
positive regulation of phosphatidylinositol 3-kinase signaling






mitogen-activated protein kinase binding
Wnt-protein binding
positive regulation of cholesterol efflux
growth factor binding
hippo signaling
platelet-derived growth factor receptor signaling pathway
activation of JUN kinase activity
signaling receptor activity
epidermal growth factor receptor signaling pathway
Wnt signaling pathway
regulation of small GTPase mediated signal transduction
cellular response to insulin stimulus
negative regulation of ossification
non-canonical Wnt signaling pathway








G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
photoreceptor connecting cilium




RNA polymerase II cis-regulatory region sequence-specific DNA binding
RNA polymerase II transcription factor binding
cis-regulatory region sequence-specific DNA binding
transcription regulator complex 
DNA-binding transcription activator activity, RNA polymerase II-specific
chromatin
3'-5' DNA helicase activity
DNA duplex unwinding
chromatin organization






RNA polymerase II repressing transcription factor binding
catalytic step 2 spliceosome




exonucleolytic catabolism of deadenylated mRNA




chaperone-mediated protein complex assembly
ribosome
translation initiation factor activity
regulation of mRNA stability
chaperone binding
RNA polymerase III complex
ribosomal large subunit assembly
polysomal ribosome
cytosolic large ribosomal subunit
ribosomal large subunit biogenesis
positive regulation of telomerase RNA localization to Cajal body
translation
regulation of transcription from RNA polymerase II promoter in response to hypoxia
eukaryotic translation initiation factor 3 complex
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
eukaryotic 43S preinitiation complex
U4/U6 x U5 tri-snRNP complex
preribosome, large subunit precursor
cytosolic small ribosomal subunit
RNA polymerase III activity
K63-linked polyubiquitin modification-dependent protein binding
positive regulation of tyrosine phosphorylation of STAT protein
phosphoprotein phosphatase activity
peptidyl-tyrosine autophosphorylation
positive regulation of protein phosphorylation
protein tyrosine kinase activity
protein processing
protein O-linked glycosylation
flavin adenine dinucleotide binding
endoplasmic reticulum lumen
ubiquitin binding
protein transmembrane transporter activity
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process




SRP-dependent cotranslational protein targeting to membrane
NADH dehydrogenase (ubiquinone) activity
proteasomal protein catabolic process
proteasomal ubiquitin-independent protein catabolic process
























proteasome-mediated ubiquitin-dependent protein catabolic process




lens development in camera-type eye





negative regulation of fat cell differentiation
somitogenesis
endocardial cushion morphogenesis
-2 -1 0 1 2





































Next,  using  the  ratio  that was  created  by  di‐
rectly comparing the differentially expressed genes 
















observed  to  be  decreased  compared  to  controls. 
Transcription/translation  was  the  second  largest 










compared  to  control  (Figure  6G).  Vascular  had  16 








all,  RHI  and  CTE  had  similar  changes  compared  to 
controls. For RHI‐control and CTE‐control compari‐
sons that did not have the same direction of effect, 
CTE‐control  comparisons  always  had  reduced  en‐
richment of those processes. 









tially  expressed  in  the  sulcus  compared  with  the 
crest among all three groups (Figure 7A). 331 of 333 
genes  had  the  same  direction  of  effect  among  all 
three  diagnostic  groups  (Figure  7B). Only  2  genes, 




ogy  (GO)  analysis  was  performed  (Figure  7C).  The 






























genes  were  increased,  and  292  genes  were  de‐
creased  in  the  sulcus  relative  to  the  crest  (Figure 
7H). 136 genes met FRD corrected significance < 0.1. 
GO  analysis  of  CTE  specific  biological  processes 






















































































































Negative regulation of nervous system development
ensheathment of neurons
supramolecular fiber organization




regulation of ion transport
monocarboxylic acid metabolic process
developmental growth
monovalent inorganic cation homeostasis
neuronal system
chemical synaptic transmission













signaling by Rho GTPase
negative regulation of immune system process
chondrocyte differentiation involved in endochondral bone morphogenesis




regulation of interleukin-4-mediated signaling pathway
PKMTs methylate histone lysines
hippo signaling pathway
in utero embryonic development
PID HIF1 TFPATHWAY




regulation of ATP metabolic process
mitochondrial gene expression




INO80 chromatin remodeling complex
establishment of protein localization to organelle
regulation of oxidative phosphorylation
ubiquitin-dependent protein catabolic process
SAGA complex, GCN5-linked
protein processing in endoplasmic reticulum
cytosolic transport
mitotic cytokinesis
ribosomal large subunit biogenesis
detection of chemical stimulus involved in sensory perceptioon of taste
HIV transcription initiation
positive regulation of monocyte differentiation
subpallium development
regulation of endodermal cell differentiation
actin filament-based movement
cellular response to biotic stimulus
multi-organism behavior
myometrial relaxation and contraction pathways
PID delta NP63 pathway
negative regulation of response to external stimulus
response to metal ion
herpes simplex virus 1 infection
hijack of ubiquitination by SARS-CoV-2
DNA-templated transcription, elongation
vacuole organization
cellular reponse to hypoxia
macrophage markers
cellular cation homeostasis
ATF6-mediated unfolded protein response
negative regulation of cellular component movement
G protein-coupled purinergic receptor signaling pathway
Common GO Terms
Unique RHI GO terms
Unique CTE GO terms




















Building on previous work  suggesting  that  al‐
tered  neuroinflammation  is  an  early  event  in  CTE, 
here we have demonstrated that there is a complex 









comparing  what  genes  and  biological  processes 
were  altered  in  the  sulcus  compared  to  the  crest, 
several higher order biological categories were ob‐














trocyte  development,  scavenger  receptor  activity, 
regulation  of  immune  response,  leukocyte  migra‐
tion, and antigen processing compared to the con‐
trols.  Additionally,  neuronal  processes  were  ele‐
vated  after  RHI  and  during  CTE  relative  to  control 
cases, possibly suggesting injured neurons might in‐
duce compensatory mechanisms  in efforts  to miti‐
gate  RHI  induced  damage.  These  complex  altera‐
tions  could  also  be  observed  in  transcrip‐
tional/translational,  cytoskeletal,  ECM,  mitochon‐
dria/metabolism,  signaling,  vascular,  endocyto‐
sis/exocytosis, and protein processing processes as 






and mitochondria  related;  and within CTE,  altered 
genes  were  immune  and  inflammation  related. 
Overall,  we  have  built  on  previous  work  and  ex‐
panded  our  understanding  of  the  complex  neuro‐












cant  upregulation  in  complement  genes  C4A  and 
C4B  suggesting  a  persistent  innate  immune  re‐
sponse and activation of  the  complement  cascade 
was present in the frontal cortex. Complement has 
a wide variety of functions, but in the context of neu‐





in  synaptic  pruning  in  schizophrenia  [28],  and  C4 












appeared  to  be  a  significant  neutrophil  response 
found across the sulcus and the crest. Several neu‐
trophil  related  genes  such  as  CD177,  S100A8, 
S100A9,  BPI,  and  LCN2,  and  multiple  neutrophil 
GSEA processes were highly increased. However, it 
is  possible  that  the  observed  neutrophil  response 
could be related  to various causes of death as op‐
posed to contact sport exposure. Future work will be 








and  a  long‐term  neutrophil  response.  Altogether, 
these results demonstrate that there is a prominent 
neuroinflammatory  response  found  in  the  frontal 
cortex  of  subjects who experience  repetitive  head 
trauma. However, it is likely that changes that occur 
uniformly  in both the sulcus and crest do not  fully 
explain  the  mechanisms  behind  p‐tau  deposition 










Although  the  sulcus  and  crest  are  only  sepa‐
rated by centimeters, our current result suggest that 
each region has a unique environment even in the 
absence on  trauma or  neurodegenerative  disease. 
When comparing the sulcus to the crest across each 
group, there was high agreement in the direction of 
effect  observed  in  all  the  processes  between  con‐
trol, RHI, and CTE. These results provide novel infor‐
mation  on  basic  neuroanatomy of  how  closely  re‐
lated tissue regions might be significantly different 
and  result  in  unique  neuropathologic  features.  To 
our knowledge, this is the first study to report such 




rons  and  supporting  cells  or  there  is  a  persistent 
neuronal  impairment found in the sulcus across all 
groups.  Regardless  which  is  correct,  it  is  possible 
that  an  impaired  or  reduced  neuronal  response 






tion.  The  primed  phenotype  could  be  consistent 
with  having more  glial  present  or  the  current  glia 
might  be  predisposed  to  have  a  more  severe  im‐
mune  reaction.  Additionally,  the  sulcus  was  ob‐
served to be positively enriched in ECM and vascular 
processes  compared  to  the  crest,  further  demon‐
strating the sulcus is comprised of a unique environ‐












be  very  similar  in many  genes  and  biological  pro‐
cesses that were altered in the sulcus compared to 
controls (Figure 5). The changes that were observed 
to  be  consistent  between  the  RHI  and  CTE  group 
could be interpreted as trauma related alterations, 
as a common feature of both groups is they share a 







sition  [7].  When  examining  which  biological  pro‐
cesses were altered  in  the  sulcus,  it was observed 
that  the upregulated processes were more related 
to foreign object recognition, antigen presentation, 
and  lysosomal  function,  while  the  downregulated 
processes  were  related  to  inflammatory  cytokine 
production  and  other  elements  related  to  neuro‐
degeneration.  This  is  consistent with  our  previous 






is  related  to  lysosomal  and phagocytic  alterations, 
has  been  also  found  to  relate  to  CTE  severity  [5]. 
Overall,  the  surprising  downregulation  of multiple 
immune‐related processes may suggest that an im‐
paired immune response following RHI predisposes 
individuals  to developing  initial  tau pathology CTE. 
















that  there  was  a  strong  metabolic  deficit  present 
even before pathology occurs. Mitochondrial activ‐
ity  is heavily  tied  to  the health of  the cell and any 








or  what  might  be  upstream  of  the  mitochondrial 
dysfunction,  but  these  results  point  towards  an‐
other  possible  therapeutic  target  to  treat  disease 
before p‐tau deposition even begins. 
Finally, we investigated the contribution of p‐
tau pathology  to  the  sulcal  specific  genetic  altera‐
tions.  When  directly  comparing  sulcal  specific 
changes found in RHI and CTE, very few differences 
were  observed.  This  was  unsurprising  as  our  CTE 
group was restricted to cases with low stage CTE and 
had  minimal  tau  pathology.  Therefore,  it  is  likely 
that  exposure  to  repetitive  head  trauma  was  a 
stronger  driving  force  for  sulcal  specific  changes 
than p‐tau pathology  in these  individuals.  It  is also 








were  related  to  immune  and  cell  damage  further 
highlighting the possible connection between p‐tau 





ological  processes  are  novel  targets  for  future  bi‐














mechanistically  related  to  pathologic  or  healthy 










In  conclusion,  these  results  provide  clear  evi‐
dence  that  there  is  a  complex molecular  response 
occurring in the sulcus compared to the gyral crest. 







mation,  or  other  neurodegenerative  related  re‐
sponses,  rather,  it  was  more  focused  on  antigen 
presentation,  phagocytosis,  and  wound  repair  re‐
sponses.  In  addition  to  complex  immune  changes, 
early  mitochondrial,  vascular,  ECM,  and  neuronal 
activity  are  all  affected  during  repetitive  head 
trauma  induced  damage  and  early  tau  deposition, 
and represent possible avenues to halt CTE patho‐
genesis and prevent disease. These results help re‐
fine  our  understanding  of  the  neuroinflammatory 
Free Neuropathology 2:21 (2021) Cherry et al 




environment present during disease and will help 
guide the discovery of future therapeutic strategies 
and novel biomarkers. Future studies will be crucial 
to further dissect and study the observed biological 
processes provided here to better understand the 
full spectrum of early disease. 
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